Gaelle Munsch
Overview
Explore the profile of Gaelle Munsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bezerra O, Rodger M, Munsch G, Kovacs M, Le Gal G, Morange P, et al.
J Thromb Haemost
. 2025 Jan;
PMID: 39848545
Background: Whether to stop oral anticoagulants after a first unprovoked venous thromboembolism (VTE) is challenging, partially due to an intriguingly higher risk of VTE recurrence (rVTE) in men after therapy...
2.
Munsch G, Thibord F, Bezerra O, Brody J, van Hylckama Vlieg A, Gourhant L, et al.
medRxiv
. 2024 Dec;
PMID: 39677447
Venous thromboembolism (VT) is a frequent (annual incidence of 1 to 2 per 1,000) and potentially life-threatening (case-fatality rate up to 10%) disease. VT is associated with serious short-term and...
3.
Fawaz S, Marti S, Dufossee M, Pucheu Y, Gaufroy A, Broitman J, et al.
Elife
. 2024 Dec;
13.
PMID: 39665621
Background: Clonal hematopoiesis of indeterminate potential (CHIP) was initially linked to a twofold increase in atherothrombotic events. However, recent investigations have revealed a more nuanced picture, suggesting that CHIP may...
4.
Ibrahim-Kosta M, El Harake S, Leclercq B, De Mari C, Secondi J, Paoletti E, et al.
J Thromb Haemost
. 2024 Nov;
23(3):937-946.
PMID: 39486690
Background: The long-term recurrence risk after a pregnancy-associated venous thromboembolism (VTE) is sparsely assessed. Objectives: To determine the rate of recurrence after a pregnancy-associated VTE and identify associated risk factors....
5.
Gendre B, Martinez-Perez A, Kleber M, van Hylckama Vlieg A, Boland A, Olaso R, et al.
J Am Heart Assoc
. 2024 Oct;
13(21):e034943.
PMID: 39424413
Background: Factor V (FV) is a key molecular player in the coagulation cascade. FV plasma levels have been associated with several human diseases, including thrombosis, bleeding, and diabetic complications. So...
6.
Vacik Diaz R, Munsch G, Iglesias M, Pallares Robles A, Ibrahim-Kosta M, Nourse J, et al.
J Thromb Haemost
. 2024 Jun;
22(9):2531-2542.
PMID: 38838952
Background: The thrombin generation assay (TGA) evaluates the potential of plasma to generate thrombin over time, providing a global picture of an individual's hemostatic balance. Objectives: This study aimed to...
7.
Hasser E, Brody J, Bartz T, Thibord F, Li-Gao R, Kauko A, et al.
J Thromb Haemost
. 2024 May;
22(8):2261-2269.
PMID: 38782299
Background: Increased risk of venous thromboembolism (VTE) is a life-threatening side effect for users of oral contraceptives (OCs) or hormone therapy (HT). Objectives: To investigate the potential for genetic predisposition...
8.
Iglesias M, Sanchez-Rivera L, Ibrahim-Kosta M, Naudin C, Munsch G, Goumidi L, et al.
Nat Commun
. 2023 Nov;
14(1):7752.
PMID: 38012230
No abstract available.
9.
Munsch G, Proust C, Labrouche-Colomer S, Aissi D, Boland A, Morange P, et al.
NAR Genom Bioinform
. 2023 Jun;
5(2):lqad062.
PMID: 37388819
Over the last years, there has been a considerable expansion of genome-wide association studies (GWAS) for discovering biological pathways underlying pathological conditions or disease biomarkers. These GWAS are often limited...
10.
Iglesias M, Sanchez-Rivera L, Ibrahim-Kosta M, Naudin C, Munsch G, Goumidi L, et al.
Nat Commun
. 2023 Jun;
14(1):3280.
PMID: 37286573
Venous thromboembolism (VTE) is a common, multi-causal disease with potentially serious short- and long-term complications. In clinical practice, there is a need for improved plasma biomarker-based tools for VTE diagnosis...